secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001493152-26-008658
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical confirms no business disruption amid Middle East events, progresses LIBERTY commercial launch
--------------------------------------------------------------------------------

- No business disruption in USA or Israel; all personnel operational, lead manufacturing partner fully functional.
- LIBERTY system received FDA clearance; limited market release began late 2025; full market release at SIR April 2026.
- Hired additional U.S. sales representatives and a Director of Health Economics and Outcomes Research (HEOR) for commercial expansion.
- Sufficient U.S. inventory maintained; building additional stock via third-party logistics partner for anticipated demand.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226008658/0001493152-26-008658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226008658/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer